89 related articles for article (PubMed ID: 28285963)
1. Clear cell colorectal carcinoma: Time to clarify diagnosis.
Remo A; Grillo F; Mastracci L; Fassan M; Sina S; Zanella C; Parcesepe P; Damiano Urso E; Pancione M; Bortuzzo G; Scarpa A; Manfrin E
Pathol Res Pract; 2017 May; 213(5):447-452. PubMed ID: 28285963
[TBL] [Abstract][Full Text] [Related]
2. Difficulties of clinical and histopathological diagnosis in advanced vulvar clear cell carcinoma.
Herghelegiu CG; Neacşu A; Oprescu ND; Cărbunaru AE; Brăila AD; Curea FG; Marcu ML; Ioan RG; Bohîlţea RE
Rom J Morphol Embryol; 2018; 59(4):1233-1237. PubMed ID: 30845306
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
Li M; Li H; Liu F; Bi R; Tu X; Chen L; Ye S; Cheng X
J Ovarian Res; 2017 Feb; 10(1):9. PubMed ID: 28187748
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary.
Umezu T; Shibata K; Kajiyama H; Yamamoto E; Nawa A; Kikkawa F
J Clin Pathol; 2010 Nov; 63(11):962-6. PubMed ID: 20972242
[TBL] [Abstract][Full Text] [Related]
5. ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component.
Nishikimi K; Kiyokawa T; Tate S; Iwamoto M; Shozu M
Histopathology; 2015 Dec; 67(6):866-71. PubMed ID: 25913291
[TBL] [Abstract][Full Text] [Related]
6. Are oestrogens and genetic predisposition etiologic factors in the development of clear cell carcinoma of the peritoneum?
Wuntakal R; Lawrence A
Med Hypotheses; 2013 Feb; 80(2):167-71. PubMed ID: 23265355
[TBL] [Abstract][Full Text] [Related]
7. Clear cell carcinoma of the nasal cavity: A case report from histopathological viewpoint.
Imai T; Satoh I; Matsumoto K; Ito S; Asada Y; Kato K; Koshiba Y; Saijo S; Matsuura K
Auris Nasus Larynx; 2016 Feb; 43(1):108-11. PubMed ID: 26140982
[TBL] [Abstract][Full Text] [Related]
8. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
9. Right Colon Clear Cell Carcinoma of Müllerian Type.
Khefacha F; Triki W; Ayed K; Abbassi I; Baccar A; Baraket O; Bouchoucha S
Case Rep Gastroenterol; 2022; 16(2):469-479. PubMed ID: 36157611
[TBL] [Abstract][Full Text] [Related]
10. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
[TBL] [Abstract][Full Text] [Related]
11. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
[TBL] [Abstract][Full Text] [Related]
12. Clear cell carcinoma of the base of the tongue: case report and literature review.
Watanabe K; Okumura Y; Hashimoto K; Suzuki T
Ann Otol Rhinol Laryngol; 2015 Jan; 124(1):55-61. PubMed ID: 25026960
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.
Ma FH; Qiang JW; Zhang GF; Li HM; Cai SQ; Rao YM
J Ovarian Res; 2016 Jul; 9(1):40. PubMed ID: 27377917
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features.
Fadare O; Parkash V; Dupont WD; Acs G; Atkins KA; Irving JA; Pirog EC; Quade BJ; Quddus MR; Rabban JT; Vang R; Hecht JL
Am J Surg Pathol; 2012 Aug; 36(8):1107-18. PubMed ID: 22790851
[TBL] [Abstract][Full Text] [Related]
16. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
17. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
18. Clear cell carcinoma of testis: A review.
Lin M; Awalt H; Ayala AG; Ro JY
Ann Diagn Pathol; 2019 Jun; 40():26-29. PubMed ID: 30921621
[TBL] [Abstract][Full Text] [Related]
19. Clear cell carcinoma, not otherwise specified, of salivary glands: a clinicopathologic study of 4 cases and review of the literature.
Yang S; Zhang J; Chen X; Wang L; Xie F
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Nov; 106(5):712-20. PubMed ID: 18602286
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract.
Vang R; Whitaker BP; Farhood AI; Silva EG; Ro JY; Deavers MT
Int J Gynecol Pathol; 2001 Jul; 20(3):252-9. PubMed ID: 11444201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
